UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

LEAP THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

2834

 

27-4412575

(State of Incorporation)

 

(Primary Standard Industrial
Classification Code Number)

 

(IRS Employer
Identification No.)

 

47 Thorndike Street

Suite B1-1

Cambridge, MA 02141

Telephone:  (617) 252-4343

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class
to be so registered

 

Name of each exchange on which
each class is to be registered

Common Stock, par value $0.001 per share

 

The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.   o

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.   o

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.   o

 

Securities Act registration statement file number to which this form relates:                    (if applicable)

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 


 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

ITEM 1 — DESCRIPTION OF REGISTRANT’S SECURITIES TO BE REGISTERED

 

Leap Therapeutics, Inc., a Delaware corporation (the “ Registrant ”), hereby incorporates by reference herein the description of its common stock, par value $0.001 per share, to be registered hereunder, set forth under the heading “Description of Leap Capital Stock” in the Registrant’s prospectus forming part of its Registration Statement on Form S-4 (File No. 333- 333-213794), originally filed with the Securities and Exchange Commission (the “ Commission ”) pursuant to the Securities Act of 1933, as amended (the “ Securities Act ”), on September 26, 2016, as thereafter amended and supplemented (the “ Registration Statement ”).

 

ITEM 2 — EXHIBITS

 

Pursuant to the Instructions as to Exhibits for this registration statement on Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2


 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

 

LEAP THERAPEUTICS, INC.

 

 

 

Date: January 20, 2017

By:

/s/ Christopher K. Mirabelli

 

Name:

Christopher K. Mirabelli

 

Title:

Chief Executive Officer

 

3